Loading...

Michael Pourdehnad

TitleHS CLIN INSTR-FY
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone415-353-2421
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rasco DW, Papadopoulos KP, Pourdehnad M, Gandhi AK, Hagner P, Li Y, Wei X, Chopra R, Hege K, DiMartino JF, Shih KC. A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies. Clin Cancer Res. 2018 Sep 10. PMID: 30201761.
      View in: PubMed
    2. Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK. CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL. Blood. 2015 Aug 06; 126(6):779-89. PMID: 26002965; PMCID: PMC4528065.
      View in: PubMed, PubMed Central
    3. Pourdehnad M, Truitt ML, Siddiqi IN, Ducker GS, Shokat KM, Ruggero D. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc Natl Acad Sci U S A. 2013 Jul 16; 110(29):11988-93. PMID: 23803853; PMCID: PMC3718086.
      View in: PubMed, PubMed Central
    4. Cunningham JT, Pourdehnad M, Stumpf CR, Ruggero D. Investigating Myc-dependent translational regulation in normal and cancer cells. Methods Mol Biol. 2013; 1012:201-12. PMID: 24006066; PMCID: PMC4390065.
      View in: PubMed, PubMed Central
    5. Pourdehnad M, Basu S, Duarte P, Okpaku AS, Saboury B, Hustinx R, Alavi A. Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET. Hell J Nucl Med. 2011 Sep-Dec; 14(3):219-23. PMID: 22087438.
      View in: PubMed
    6. Newberg AB, Saffer J, Farrar J, Pourdehnad M, Alavi A. Stability of cerebral blood flow measures using a split-dose technique with (99m)Tc-exametazime SPECT. Nucl Med Commun. 2005 May; 26(5):475-8. PMID: 15838432.
      View in: PubMed
    7. Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S. 18F-FDG PET in malignant lymphoma: significance of positive findings. Eur J Nucl Med Mol Imaging. 2005 Jul; 32(7):749-56. PMID: 15785956.
      View in: PubMed
    8. Hustinx R, Pourdehnad M, Kaschten B, Alavi A. PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am. 2005 Jan; 43(1):35-47. PMID: 15693646.
      View in: PubMed
    9. Mamot C, Nguyen JB, Pourdehnad M, Hadaczek P, Saito R, Bringas JR, Drummond DC, Hong K, Kirpotin DB, McKnight T, Berger MS, Park JW, Bankiewicz KS. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol. 2004 May; 68(1):1-9. PMID: 15174514.
      View in: PubMed
    10. Schmitz A, Shiue CY, Feng Q, Shiue GG, Deng S, Pourdehnad MT, Schirrmacher R, Vatamaniuk M, Doliba N, Matschinsky F, Wolf B, Rösch F, Naji A, Alavi AA. Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents. Nucl Med Biol. 2004 May; 31(4):483-91. PMID: 15093819.
      View in: PubMed
    11. Newberg A, Pourdehnad M, Alavi A, d'Aquili EG. Cerebral blood flow during meditative prayer: preliminary findings and methodological issues. Percept Mot Skills. 2003 Oct; 97(2):625-30. PMID: 14620252.
      View in: PubMed
    12. Zhuang HM, Cortés-Blanco A, Pourdehnad M, Adam LE, Yamamoto AJ, Martínez-Lázaro R, Lee JH, Loman JC, Rossman MD, Alavi A. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun. 2001 Oct; 22(10):1123-8. PMID: 11567186.
      View in: PubMed
    13. Meyer PT, Cortés-Blanco A, Pourdehnad M, Levy-Reis I, Desiderio L, Jang S, Alavi A. Inter-modality comparisons of seizure focus lateralization in complex partial seizures. Eur J Nucl Med. 2001 Oct; 28(10):1529-40. PMID: 11685497.
      View in: PubMed
    14. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001 Sep; 42(9):1412-7. PMID: 11535734.
      View in: PubMed
    15. Zhuang H, Yamamoto AJ, Sinha P, Pourdehnad M, Liu Y, Alavi A. Similar pelvic abnormalities on FDG positron emission tomography of different origins. Clin Nucl Med. 2001 Jun; 26(6):515-7. PMID: 11353298.
      View in: PubMed
    16. Zhuang H, Pourdehnad M, Yamamoto AJ, Rossman MD, Alavi A. Intense F-18 fluorodeoxyglucose uptake caused by mycobacterium avium intracellulare infection. Clin Nucl Med. 2001 May; 26(5):458. PMID: 11317033.
      View in: PubMed
    17. Newberg A, Alavi A, Baime M, Pourdehnad M, Santanna J, d'Aquili E. The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study. Psychiatry Res. 2001 Apr 10; 106(2):113-22. PMID: 11306250.
      View in: PubMed
    18. Zhuang H, Duarte PS, Pourdehnad M, Maes A, Van Acker F, Shnier D, Garino JP, Fitzgerald RH, Alavi A. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med. 2001 Jan; 42(1):44-8. PMID: 11197979.
      View in: PubMed
    19. Zhuang H, Sinha P, Pourdehnad M, Duarte PS, Yamamoto AJ, Alavi A. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun. 2000 Sep; 21(9):793-8. PMID: 11065150.
      View in: PubMed
    20. Zhuang HM, Duarte P, Pourdehnad M, Yamamoto AJ, Loman JC, Sinha P, Alavi A. 26. Incidental findings should be included in the analysis of cost-effectiveness for evaluation of pulmonary nodules by FDG-PET. Clin Positron Imaging. 2000 Jul; 3(4):180. PMID: 11150783.
      View in: PubMed
    21. Couturier O, Le Rest C, Gournay J, Pourdehnad M, Bridji B, Turzo A, Bizais Y. Gastric emptying of solids: estimates of lag phase and constant emptying times. Nucl Med Commun. 2000 Jul; 21(7):665-75. PMID: 10994671.
      View in: PubMed
    22. Zhuang H, Duarte PS, Pourdehnad M, Li P, Alavi A. Standardized uptake value as an unreliable index of renal disease on fluorodeoxyglucose PET imaging. Clin Nucl Med. 2000 May; 25(5):358-60. PMID: 10795695.
      View in: PubMed
    23. Teff KL, Alavi A, Chen J, Pourdehnad M, Townsend RR. Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender. Am J Physiol. 1999 Mar; 276(3 Pt 2):R707-14. PMID: 10070130.
      View in: PubMed
    24. Cesano A, Wortman JA, Pourdehnad M, Visonneau S, Mozley D, Bhatnagar A, Alavi A, Santoli D. Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: implications for adoptive cell therapy of cancer. Int J Oncol. 1999 Feb; 14(2):233-44. PMID: 9917497.
      View in: PubMed
    Michael's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (157) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (7) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑